Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus

Next Previous
X
Search
Trial Profile

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 May 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Interferon alpha kinoid (Primary) ; Montanide ISA-51
  • Indications Systemic lupus erythematosus
  • Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
  • Sponsors Neovacs

    • Most Recent Events

    • 18 Apr 2023 According to a Neovacs media release, the main study has been completed.
    • 18 Apr 2023 According to a Neovacs media release, full results were presented at the 13th2019 international lupus congress.
    • 18 Mar 2023 According to a Neovacs media release, based on results from this trial, the partnership agreement between Neovacs and Biosense allows the resumption of clinical trials in China, fully supported by Biosense Global. Biosense Global will now bear the entire costs of these new clinical trials in China.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top